Prevalence and susceptibility of Shigella species to 11 antibiotics in a Kuwait Teaching Hospital

Journal of Chemotherapy

Volumn 10, Issue 4, 1998, Pages 285-290

  Jamal, W Y ^a   Rotimi, V O ^a   Chugh, T D ^a   Pal, T ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

Antibiotic susceptibility; Diarrhea; Dysentery; Gastroenteritis; Gulf War; Prevalence; Shigella spp.; Traveller's diarrhea

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CEFALOTIN; CEFOTAXIME; CEFUROXIME; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; PIPERACILLIN;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CHILD; CONTROLLED STUDY; DIARRHEA; FECES ANALYSIS; GASTROENTERITIS; HUMAN; MINIMUM INHIBITORY CONCENTRATION; SHIGELLA; TRAVELLER DIARRHEA;

EID: 0031829536     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.1998.10.4.285     Document Type: Article

References (33)

1. Dupont HL. Shigella species (bacillary dysentery). In: Mandell G, Douglas, G, Bennett JE, eds. Principles and Practice of Infectious Diseases. London. Churchill Livingstone, 1995: 2033-2039.
2. Vila J, Gascon J, Abdalla S, et al. Antimicrobial resistance of Shigella isolates causing traveler's diarrhoea. Antimicrob Agents Chemother 1994; 38: 2668-2670.
3. Tauxe RV, Puhr ND, Wells JG, Hargrett-Bean N, Blake PA. Antimicrobial resistance of Shigella isolates in the USA: Importance of international travelers. J Infect Dis 1990; 162: 1107-1111.
4. Bennish ML, Salam MA, Hossain MA, et al. Antimicrobial resistance of Shigella isolates in Bangladesh, 1983-1990: increasing frequency of strains multiply resistant to ampicillin. trimethoprim/sulfamethoxazole and nalidixic acid Clin Infect Dis 1992; 14: 1055-1060.
5. Pal SC. Epidemic bacillary dysentery in West Bengal, India (letter). Lancet 1984; 1: 1462.
6. Bennish ML, Salam MA, Jesudason MV, John J. Therapy for shigellosis. II. Randomized double-blind comparison of ciprofloxacin and ampicillin. J Infect Dis 1990; 162: 711-716.
7. Lolekha S, Vibulbandhitkit S, Poonyarit P. Response to antimicrobial therapy for shigellosis in Thailand. Rev Infect Dis 1991: 13 (suppl.4): S342-346.
8. Frost JA, Willshaw GA. Barclay EA, Lemmens P, Vandepitte J. Plasmid characterization of drug-resistant Shigella dysenteriae 1 from an epidemic in central Africa. J Hyg 1995; 94: 163-172.
9. Centers for Disease Control. Multiply resistant shigellosis in a day-care center-Texas. MMWR 1986; 35: 753-755.
10. Centers for Disease Control. Nation-wide dissemination of multiply resistant Shigella sonnei following a commonsource outbreak. MMWR 1987; 36: 633-634.
11. Centers for Disease Control. Shigella dysenteriae type 1 - Guatemala. MMWR 1991; 40: 421-428.
12. Bratoeva MP, John JF. Jr. In vivo R-plasmid transfer in a patient with mixed infection of shigella dysentery. Epidemiol Infect 1994; 112: 247-252.
13. National Committee for Clinical Laboratory Standards, Approved Standard (NCCLS) Doc. M7-A3. Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically, 3rd edition. ISBN 1-56238-209-8, Villanova, PA, 1993;17-20.
14. Kambal AMM, Chowdhury NH, Al-Eissa YA, Eltigani MMT. Susceptibility of Shigella species to various antimicrobial agents in Saudi Arabia. Med Sei Res 1994; 22: 867-869.
15. Kagalwalla AF, Khan SN, Kagalwalla YA, Alola S, Yaish H. Childhood shigellosis in Saudi Arabia. Pediatr Infect Dis J 1992; 11: 215-219.
16. Ling J, Kam KM, Lam AW, French GL. Susceptibilities of Hong Kong isolates of multiply resistant Shigella spp. to 25 antimicrobial agents, including ampicillin plus sulbactam and new 4-quinolones. Antimicrob Agents Chemother 1988; 32: 20-23.
17. Harnett N. High level resistance to trimethoprim cotrimoxazole and other antimicrobial agents among clinical isolates of Shigella species in Ontario, Canada - an update. Epidemiol Infect 1992; 109: 463-472.
18. Michail IS, Fox E, Haberberger RL, Ahmed MH, Abbatte EA. Epidemiology of bacterial pathogens associated with infectious diarrhoea in Djibouti. J Clin Microbiol 1990; 28: 956-961.
19. Kain KC, Bartelouk RL, Kelly MT, et al. Etiology of childhood diarrhea in Beijing. China. J Clin Microbiol 1991; 29: 90-95.
20. Casalino M, Yusuf MW, Nicoletti M et al. A two-year study of enteric infections associated with diarrhoeal diseases in children in urban Somalia. Trans R Soc Trop Med Hyg 1988; 82: 637-641.
21. Ogunsanya TI, Rotimi VO, Adenuga A. A study of the aetiological agents of childhood diarrhoea in Lagos, Nigeria. J Med Microbiol 1994; 40: 10-14.
22. Hyams KC, Bourgeois AL, Merrell BR et al. Diarrheal disease during Operation Desert Shield. N Engl J Med 1991; 325: 1423-1428.
23. Katouli M, Pachenary A, Jaafari A et al. The role of Shigella spp. in childhood diarrhoea in Iran and their antibiotic resistance. Scand J Infect Dis 1989; 21: 415-419.
24. Admoni O, Yagupsky P, Golan A, Kenes Y, Schifroni G, Horowitz I. Epidemiological, clinical and microbiological features of shigellosis among hospitalized children in northern Israel. Scand J Infect Dis 1995; 27: 139-144.
25. Chugh TD, Suheir A, Mahboob AG, Neil L, El-Bishbishi E. Plasmid-mediated drug resistance of shigellae in Kuwait. Antonie Van Leeuwenhoek 1985; 51: 241-247.
26. Blaser MJ, Pollard RA, Feldman RA. Shigella infections in the United States, 1974-1980. J Infect Dis 1983; 47: 771-755.
27. Olukoya DK, Oni O. Plasmid profile analysis and antimicrobial susceptibility patterns of shigella isolates from Nigeria. Epidemiol Infect 1990; 105: 59-64.
28. Sack RB, Rahman M, Yunus M, Khan EH. Antimicrobial resistance in organisms causing diarrhoeal disease. Clin Infect Dis 1997; 24 (Suppl. 1): S102-105.
29. Araj GF, Uwaydah MM, Alami SY. Antimicrobial susceptibility patterns of bacterial isolates at American University Medical Center in Lebanon. Diagn Microbiol Infect Dis 1994; 20: 151-158.
30. Alkan M, Salzstein E, Simu A. Four cases of Shigella septicemia in Israel. Eur J Clin Microbiol 1985, 4: 417-418.
31. Ruderman JW, Stoller KP, Pomerance JJ. Blood stream invasion of Shigella sonnei in an asymptomatic newborn infant. Pediatr Infect Dis 1986; 5: 379-380.
32. Hooper DC, Wolfson MA. Flouroquinolones: pharmacology, clinical uses and toxicities in humans. Antimicrob Agents Chemother 1985; 28: 716-721.
33. Acar JF, Goldstein FW. Trends in bacterial resistance to flouroquinolones. Clin Infect Dis 1995; 24 (Suppl. 1): S67-73.